| Symbol |
Name |
Standardized Value |
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
3.527
|
|
CD99L2
|
CD99 molecule-like 2
|
3.436
|
|
CD99
|
CD99 molecule
|
3.427
|
|
CD34
|
CD34 molecule
|
3.388
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
3.239
|
|
CALD1
|
caldesmon 1
|
2.716
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
2.66
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
2.576
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
2.564
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
2.444
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
2.408
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
2.402
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
2.289
|
|
FGF23
|
fibroblast growth factor 23
|
2.285
|
|
SYP
|
synaptophysin
|
2.261
|
|
MYOG
|
myogenin (myogenic factor 4)
|
2.242
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
2.208
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
2.206
|
|
IGF2
|
insulin-like growth factor 2
|
2.144
|
|
EWSR1
|
EWS RNA-binding protein 1
|
2.12
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
2.099
|
|
SSX2B
|
synovial sarcoma, X breakpoint 2B
|
2.063
|
|
GFAP
|
glial fibrillary acidic protein
|
2.041
|
|
NCOA2
|
nuclear receptor coactivator 2
|
2.025
|
|
MYOD1
|
myogenic differentiation 1
|
1.975
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
1.971
|
|
SSX4B
|
synovial sarcoma, X breakpoint 4B
|
1.97
|
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
1.964
|
|
CALB2
|
calbindin 2
|
1.949
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.938
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.932
|
|
CD68
|
CD68 molecule
|
1.909
|
|
ETV6
|
ets variant 6
|
1.884
|
|
KRT7
|
keratin 7, type II
|
1.811
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.804
|
|
TP53
|
tumor protein p53
|
1.786
|
|
MME
|
membrane metallo-endopeptidase
|
1.782
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.782
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.754
|
|
WT1
|
Wilms tumor 1
|
1.745
|
|
NF2
|
neurofibromin 2 (merlin)
|
1.736
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
1.727
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
1.725
|
|
SSTR2
|
somatostatin receptor 2
|
1.713
|
|
CHGA
|
chromogranin A
|
1.697
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.68
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
1.674
|
|
TRAF7
|
TNF receptor-associated factor 7, E3 ubiquitin protein ligase
|
1.671
|
|
PGR
|
progesterone receptor
|
1.647
|
|
CCNB3
|
cyclin B3
|
1.628
|
|
PAX3
|
paired box 3
|
1.608
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.598
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
1.59
|
|
TERT
|
telomerase reverse transcriptase
|
1.581
|
|
MUC4
|
mucin 4, cell surface associated
|
1.573
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
1.55
|
|
NF1
|
neurofibromin 1
|
1.538
|
|
FUS
|
FUS RNA binding protein
|
1.528
|
|
SATB2
|
SATB homeobox 2
|
1.513
|
|
KRT5
|
keratin 5, type II
|
1.51
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.502
|
|
CDK4
|
cyclin-dependent kinase 4
|
1.488
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.483
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.482
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.461
|
|
SPECC1L
|
sperm antigen with calponin homology and coiled-coil domains 1-like
|
1.459
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.453
|
|
MAML3
|
mastermind-like 3 (Drosophila)
|
1.453
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
1.443
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.441
|
|
PAX8
|
paired box 8
|
1.439
|
|
VIM
|
vimentin
|
1.435
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.434
|
|
SST
|
somatostatin
|
1.411
|
|
NKX2-2
|
NK2 homeobox 2
|
1.404
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
1.401
|
|
KDR
|
kinase insert domain receptor
|
1.398
|
|
PTH
|
parathyroid hormone
|
1.394
|
|
KRT19
|
keratin 19, type I
|
1.385
|
|
EGR1
|
early growth response 1
|
1.377
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
1.373
|
|
TPM3
|
tropomyosin 3
|
1.368
|
|
BCAS3
|
breast carcinoma amplified sequence 3
|
1.364
|
|
KRT20
|
keratin 20, type I
|
1.362
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
1.356
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.348
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.341
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
1.34
|
|
MB
|
myoglobin
|
1.33
|
|
DUX4
|
double homeobox 4
|
1.329
|
|
MITF
|
microphthalmia-associated transcription factor
|
1.326
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
1.316
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
1.313
|
|
SFRP4
|
secreted frizzled-related protein 4
|
1.307
|
|
AFP
|
alpha-fetoprotein
|
1.292
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.292
|
|
EMP1
|
epithelial membrane protein 1
|
1.291
|
|
NKX2-1
|
NK2 homeobox 1
|
1.288
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.285
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
1.284
|
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1
|
1.284
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
1.275
|
|
NGFR
|
nerve growth factor receptor
|
1.274
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
1.257
|
|
EGFR
|
epidermal growth factor receptor
|
1.251
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.235
|
|
RET
|
ret proto-oncogene
|
1.234
|
|
GLMN
|
glomulin, FKBP associated protein
|
1.229
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
1.228
|
|
SMARCE1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1
|
1.223
|
|
REN
|
renin
|
1.222
|
|
CD1B
|
CD1b molecule
|
1.217
|
|
CD1E
|
CD1e molecule
|
1.213
|
|
ZC3H7B
|
zinc finger CCCH-type containing 7B
|
1.211
|
|
CD1A
|
CD1a molecule
|
1.202
|
|
CLDN1
|
claudin 1
|
1.189
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
1.183
|
|
ETV4
|
ets variant 4
|
1.163
|
|
CCND1
|
cyclin D1
|
1.161
|
|
BEND2
|
BEN domain containing 2
|
1.159
|
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1
|
1.157
|
|
PDPN
|
podoplanin
|
1.156
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.144
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
1.139
|
|
CD1C
|
CD1c molecule
|
1.136
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.133
|
|
CLDN7
|
claudin 7
|
1.133
|
|
INS
|
insulin
|
1.131
|
|
VWF
|
von Willebrand factor
|
1.13
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
1.128
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
1.127
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.118
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
1.118
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
1.113
|
|
FOXR2
|
forkhead box R2
|
1.113
|
|
COL1A1
|
collagen, type I, alpha 1
|
1.095
|
|
HMGA2
|
high mobility group AT-hook 2
|
1.093
|
|
CD1D
|
CD1d molecule
|
1.089
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.088
|
|
KRT8
|
keratin 8, type II
|
1.088
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
1.086
|
|
LMNA
|
lamin A/C
|
1.071
|
|
SLC26A11
|
solute carrier family 26 (anion exchanger), member 11
|
1.069
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
1.068
|
|
ESR1
|
estrogen receptor 1
|
1.064
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.064
|
|
KRT18
|
keratin 18, type I
|
1.06
|
|
MTMR12
|
myotubularin related protein 12
|
1.058
|
|
TPM4
|
tropomyosin 4
|
1.056
|
|
FH
|
fumarate hydratase
|
1.05
|
|
IFNA7
|
interferon, alpha 7
|
1.049
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
1.046
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
1.046
|
|
FLT4
|
fms-related tyrosine kinase 4
|
1.044
|
|
PAX7
|
paired box 7
|
1.04
|
|
IRF2BP2
|
interferon regulatory factor 2 binding protein 2
|
1.037
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
1.036
|
|
NCOA1
|
nuclear receptor coactivator 1
|
1.029
|
|
IFNA16
|
interferon, alpha 16
|
1.028
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
1.028
|
|
IFNA10
|
interferon, alpha 10
|
1.027
|
|
IFNA14
|
interferon, alpha 14
|
1.027
|
|
IFNA21
|
interferon, alpha 21
|
1.027
|
|
IFNA8
|
interferon, alpha 8
|
1.026
|
|
IFNA6
|
interferon, alpha 6
|
1.026
|
|
IFNA5
|
interferon, alpha 5
|
1.025
|
|
IFNA13
|
interferon, alpha 13
|
1.024
|
|
IFNA4
|
interferon, alpha 4
|
1.022
|
|
YAP1
|
Yes-associated protein 1
|
1.021
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
1.019
|
|
ETV1
|
ets variant 1
|
1.019
|
|
OR5D16
|
olfactory receptor, family 5, subfamily D, member 16
|
1.016
|
|
F8
|
coagulation factor VIII, procoagulant component
|
1.014
|
|
H3-3A
|
H3.3 histone A
|
1.014
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.012
|
|
PDZRN3
|
PDZ domain containing ring finger 3
|
1.002
|
|
KRT34
|
keratin 34, type I
|
1.002
|
